Genfit Stock (NASDAQ: GNFT) stock price, news, charts, stock research, profile.
Open | $3.79 |
Close | $3.61 |
Volume / Avg. | 4.80K / 22.87K |
Day Range | 3.61 - 3.79 |
52 Wk Range | 2.89 - 6.05 |
Market Cap | $180.00M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 36 |
Short Interest | 0.2% |
Days to Cover | 1.36 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Genfit (NASDAQ:GNFT) through any online brokerage.
Other companies in Genfit’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Skye Bioscience (NASDAQ:SKYE), bluebird bio (NASDAQ:BLUE), Inovio Pharmaceuticals (NASDAQ:INO) and Monte Rosa Therapeutics (NASDAQ:GLUE).
There is no analysis for Genfit.
Genfit has a consensus price target of $11.50.
The stock price for Genfit (NASDAQ: GNFT) is $3.61 last updated June 28, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Genfit.
Genfit’s H1 earnings are confirmed for Wednesday, September 18, 2024.
There is no upcoming split for Genfit.
Genfit is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.